Long-Term Cyclophosphamide Treatment in a Case with Serpiginous Choroiditis

Purpose: To report the effect of long-term therapy with the alkylating agent cyclophosphamide in a case with serpiginous choroiditis and thus to contribute to the previously reported few cases showing the beneficial effect of long-term cyclophosphamide therapy for serpiginous choroiditis. Procedures...

Full description

Bibliographic Details
Main Author: Ozlem G. Sahin
Format: Article
Language:English
Published: Karger Publishers 2010-10-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:http://www.karger.com/Article/FullText/321401
_version_ 1819209225438494720
author Ozlem G. Sahin
author_facet Ozlem G. Sahin
author_sort Ozlem G. Sahin
collection DOAJ
description Purpose: To report the effect of long-term therapy with the alkylating agent cyclophosphamide in a case with serpiginous choroiditis and thus to contribute to the previously reported few cases showing the beneficial effect of long-term cyclophosphamide therapy for serpiginous choroiditis. Procedures: Oral cyclophosphamide therapy for 12 months in a case with unilateral active serpiginous choroiditis. Results: The active lesion responded well to long-term therapy with cyclophosphamide without recurrences and significant systemic side-effects. Conclusions: Long-term therapy with cyclophosphamide for serpiginous choroiditis is effective for improving vision and preventing recurrences.
first_indexed 2024-12-23T05:51:54Z
format Article
id doaj.art-31d1ab9a91b64f3da966e891833b867c
institution Directory Open Access Journal
issn 1663-2699
language English
last_indexed 2024-12-23T05:51:54Z
publishDate 2010-10-01
publisher Karger Publishers
record_format Article
series Case Reports in Ophthalmology
spelling doaj.art-31d1ab9a91b64f3da966e891833b867c2022-12-21T17:57:55ZengKarger PublishersCase Reports in Ophthalmology1663-26992010-10-0112717610.1159/000321401321401Long-Term Cyclophosphamide Treatment in a Case with Serpiginous ChoroiditisOzlem G. SahinPurpose: To report the effect of long-term therapy with the alkylating agent cyclophosphamide in a case with serpiginous choroiditis and thus to contribute to the previously reported few cases showing the beneficial effect of long-term cyclophosphamide therapy for serpiginous choroiditis. Procedures: Oral cyclophosphamide therapy for 12 months in a case with unilateral active serpiginous choroiditis. Results: The active lesion responded well to long-term therapy with cyclophosphamide without recurrences and significant systemic side-effects. Conclusions: Long-term therapy with cyclophosphamide for serpiginous choroiditis is effective for improving vision and preventing recurrences.http://www.karger.com/Article/FullText/321401Alkylating agentCyclophosphamideSerpiginous choroiditis
spellingShingle Ozlem G. Sahin
Long-Term Cyclophosphamide Treatment in a Case with Serpiginous Choroiditis
Case Reports in Ophthalmology
Alkylating agent
Cyclophosphamide
Serpiginous choroiditis
title Long-Term Cyclophosphamide Treatment in a Case with Serpiginous Choroiditis
title_full Long-Term Cyclophosphamide Treatment in a Case with Serpiginous Choroiditis
title_fullStr Long-Term Cyclophosphamide Treatment in a Case with Serpiginous Choroiditis
title_full_unstemmed Long-Term Cyclophosphamide Treatment in a Case with Serpiginous Choroiditis
title_short Long-Term Cyclophosphamide Treatment in a Case with Serpiginous Choroiditis
title_sort long term cyclophosphamide treatment in a case with serpiginous choroiditis
topic Alkylating agent
Cyclophosphamide
Serpiginous choroiditis
url http://www.karger.com/Article/FullText/321401
work_keys_str_mv AT ozlemgsahin longtermcyclophosphamidetreatmentinacasewithserpiginouschoroiditis